共 50 条
- [21] Neoadjuvant PD-1 blockade in lung cancer: we're not in Kansas anymoreJOURNAL OF THORACIC DISEASE, 2018, 10 (08) : 4686 - 4688Cohen, BrianMarshall, M. Blair
- [22] Neoadjuvant PD-1 blockade in patients with resectable desmoplastic melanoma (SWOG 1512).JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)Kendra, Kari LynnMoon, JamesEroglu, ZeynepHu-Lieskovan, SiwenCarson, William EdgarWada, David A.Plaza, Jose A.In, Gino KimIkeguchi, AlexandraHyngstrom, John RobertBrohl, Andrew ScottChmielowski, BartoszKhushalani, Nikhil I.Markowitz, JosephMonroe, MarcusGrossmann, Kenneth F.Sondak, Vernon K.Sharon, EladWu, MichaelRibas, Antoni
- [23] Neoadjuvant-Adjuvant vs Neoadjuvant-Only PD-1 and PD-L1 Inhibitors for Patients With Resectable NSCLCJAMA NETWORK OPEN, 2024, 7 (03) : E241285Zhou, YixinLi, AnlinYu, HuiWang, YuhongZhang, XuanyeQiu, HuijuanDu, WeiLuo, LinfengFu, ShaZhang, LiHong, Shaodong
- [24] A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanomaNATURE MEDICINE, 2019, 25 (03) : 454 - +Huang, Alexander C.Orlowski, Robert J.Xu, XiaoweiMick, RosemarieGeorge, Sangeeth M.Yan, Patrick K.Manne, SasikanthKraya, Adam A.Wubbenhorst, BradleyDorfman, LizaD'Andrea, KurtWenz, Brandon M.Liu, ShujingChilukuri, LakshmiKozlov, AndrewCarberry, MaryGiles, LydiaKier, Melanie W.Quagliarello, FelixMcGettigan, SuzanneKreider, KristinAnnamalai, LakshmananZhao, QingMogg, RobinXu, WeiBlumenschein, Wendy M.Yearley, Jennifer H.Linette, Gerald P.Amaravadi, Ravi K.Schuchter, Lynn M.Herati, Ramin S.Bengsch, BertramNathanson, Katherine L.Farwell, Michael D.Karakousis, Giorgos C.Wherry, E. JohnMitchell, Tara C.
- [25] Immunogenic cell death inducers and PD-1 blockade as neoadjuvant therapy for rectal cancerONCOIMMUNOLOGY, 2024, 13 (01):Wang, YanZhao, LiweiZhang, ZhenLiu, Peng
- [26] A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanomaNature Medicine, 2019, 25 : 454 - 461Alexander C. HuangRobert J. OrlowskiXiaowei XuRosemarie MickSangeeth M. GeorgePatrick K. YanSasikanth ManneAdam A. KrayaBradley WubbenhorstLiza DorfmanKurt D’AndreaBrandon M. WenzShujing LiuLakshmi ChilukuriAndrew KozlovMary CarberryLydia GilesMelanie W. KierFelix QuagliarelloSuzanne McGettiganKristin KreiderLakshmanan AnnamalaiQing ZhaoRobin MoggWei XuWendy M. BlumenscheinJennifer H. YearleyGerald P. LinetteRavi K. AmaravadiLynn M. SchuchterRamin S. HeratiBertram BengschKatherine L. NathansonMichael D. FarwellGiorgos C. KarakousisE. John WherryTara C. Mitchell
- [27] NEOADJUVANT PD-1 ANTIBODY BLOCKADE REMODELS THE IMMUNE MICROENVIRONMENT OF METASTATIC BRAIN TUMORSNEURO-ONCOLOGY, 2020, 22 : 212 - 213Sun, LuKienzler, JennyLee, AlexanderChow, FrancesChavez, CarolinaYong, WilliamEverson, RichardKim, WonHugo, WillyPrins, Robert
- [28] PD-1T TILs as a Predictive Biomarker for Clinical Benefit to PD-1 Blockade in Patients with Advanced NSCLCCLINICAL CANCER RESEARCH, 2022, 28 (22) : 4893 - 4906Hummelink, Karlijnvan der Noort, VincentMuller, MirteSchouten, Robert D.Lalezari, FerryPeters, DennisTheelen, Willemijn S. M. E.Koelzer, Viktor H.Mertz, Kirsten D.Zippelius, Alfredvan den Heuvel, Michel M.Broeks, AnnegienHaanen, John B. A. G.Schumacher, Ton N.Meijer, Gerrit A.Smit, Egbert F.Monkhorst, KimThommen, Daniela S.
- [29] Neoadjuvant PD-1/PD-L1 axis blockade for patients with head and neck squamous cell carcinomaAMERICAN JOURNAL OF OTOLARYNGOLOGY, 2023, 44 (06)Huang, ShuangXiong, ChuangTan, Kui
- [30] Resistance to PD-1 blockade in melanomaLANCET ONCOLOGY, 2016, 17 (09): : E376 - E376Burki, Talha Khan